SPRIM
SFA Express — Clinical trials.
- Country
- United States
Coverage
| CN | EU | US | |
|---|---|---|---|
| regulatory-legal | ✓ | ✓ | ✓ |
Regulatorsefsa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Novel food approval-as-a-service (EU/UK/SG) | regulatory-legal | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.